Industries

Amfil Technologies Inc. (AMFE: OTC Pink Current) | AMFIL TECHNOLOGIES INC. REVENUES INCREASED to $1,542,389 FOR Q2 2017 POSTING A 4500% GROWTH RATE OVER Q2 2016

Jan 24, 2017
OTC Disclosure & News Service
Toronto, ONT, Canada

Amfil Technologies Inc. (OTC PINK: AMFE) is pleased to report that revenues for Q2 2017 increased to $1,542,389 with gross profit of $956,918 compared to $33,474 and $3,384 respectively for the same period Q2 2016. This 4500%+ increase in revenue year over year is a reflection of the Snakes & Lagers Inc. acquisition that closed in September 2016. Inventory has increased to $3,369,581 which primarily consists of nearly 500 pallets of board game inventory held in leased storage warehouse facilities close to the Snakes & Lattes locations.  

The company is currently looking into another site in Uptown Toronto which is approximately 10,000 sq. ft. and will host up to 250 customers.      

On January 13th 2017 the amendment to our articles was filed with the Secretary of State to create a preferred class of securities. Once this process is completed, there will be a reduction of over 40% of the outstanding share count. We expect the process to be completed shortly and will provide an update once finalized. The public float of the company with the DTC remains unchanged to date at 192,860,481. 

Thus
far into 2017, the company has been successful in executing its growth
based strategy for all subsidiaries, with multiple projects in the works
to increase revenues and shareholder value. We intend to provide updates on further developments in the coming weeks. 

Safe Harbor Statement   

This
news release contains statements that involve expectations, plans, or
intentions (such as those relating to future business or financial
results, new features or services, or management strategies) and other
factors discussed from time to time in the Company’s OTC Market or
Securities and Exchange Commission filings. These statements are
forward-looking and are subject to risks and uncertainties, so actual
results may vary materially. You can identify these forward-looking
statements by words such as “may,” “should,” “expect,” “anticipate,”
“believe,” “estimate,” “intend,” “plan,” and other similar expressions.
Our actual results, such as the Company’s ability to finance, market the
technology, complete and consolidate acquisition of IP, assets and
operating companies, could differ materially from those anticipated in
these forward-looking statements as a result of certain factors not
within the control of the company such as a result of various factors,
including future economic, competitive, regulatory, and market
conditions. The company cautions readers not to place undue reliance on
any such forward-looking statements, which speak only as of the date
made. The company disclaims any obligation subsequently to revise any
forward-looking statements to reflect events or circumstances after the
date of such statements or to reflect the occurrence of anticipated or
unanticipated events.   

CONTACT:  

Roger Mortimer  

Amfil Technologies Inc.  

Telephone: (647) 880-5887  

Copyright © 2017 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Most Popular

To Top